Form 4 for LAB STANDARD BIOTOOLS INC.
Accepted 2023-06-16 00:00:00 ET · period of report 2023-06-14 · accession 0001162194-23-000039 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-16 | 2023-06-14 | LAB | ELOI FENEL M | Dir | A - Grant | $0.00 | +26.4K | 98.5K | +37% | $0 |
| D | 2023-06-16 | 2023-06-14 | LAB | ELOI FENEL M | Dir | A - Grant | $0.00 | +35.4K | 35.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-14 | A | A | 26,376 | $0.00 | 98,463 | D | — | — | (F1) Consists of Restricted Stock Units. Each Restricted Stock Unit represents the right to receive one share of common stock upon vesting. The Restricted Stock Units vest in full on the earlier to occur of June 14, 2024 and one day prior to the date of the Company's next annual meeting of stockholders subject to the Reporting Person's continued service through the applicable vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-06-14 | A | A | 35,380 | $0.00 | 35,380 | D | $2.18 · — to 2033-06-14 | 35,380 Common Stock | (F2) The Option becomes exercisable in twelve equal monthly increments beginning on July 14, 2023 subject to the Reporting Person's continued service through the applicable vesting date. |